Publication | Closed Access

6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis

Induces Apoptosis-like DeathNecroptosisApoptosisImmunologyMedicineCell DeathCell-cycle ProgressionPharmacologyCell BiologyVisceral LeishmaniasisShort FormDrug Discovery